Radiotherapy uses high-energy radiation beams such as gamma rays, x-rays, and protons to kill cancerous cells by inhibiting its growth and multiplication. Radiosurgery is often used before surgery to reduce the size of a tumor prior to removal, or after surgery to destroy the cancerous cells left behind. Various types of radiation therapies such as conformal radiotherapy (CRT), intensity modulated radiotherapy (IMRT), image guided radiotherapy (IGRT), and 4-dimensional radiotherapy are widely used to treat cancer. Internal radiotherapy is given using radioactive material placed inside the body, while external beam radiotherapy delivers x-rays from outside the body, using linear accelerators and other systems. The innovative image-guided radiotherapy is used to integrate better imaging techniques for visualizing cancer tumor. External beam radiation therapy is used to treat various types of cancers, including brain tumors, bladder cancer, and bone cancers. Brachytherapy is often used to treat cancers of the head and neck, breast, cervix, prostate, and eye, while systemic radiation therapy is often used to treat certain types of thyroid cancers using radioactive iodine.
Market Dynamics
Major factors driving growth of the radiotherapy market include rising prevalence of cancer, increasing adoption of innovative targeted therapies such as radiotherapy due to side effects associated with traditional chemotherapies such as anemia and infection. For instance, according to the data provided by the World Health Organization in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. This in turn, is expected to increase demand for radiotherapy over the forecast period. Nevertheless, the opportunities for key players to provide radiotherapy products in emerging markets with increasing demand for efficacious cancer treatment are anticipated to provide better prospects for market growth over the forecast period
Key features of the study:
- This report provides in-depth analysis of the global radiotherapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global radiotherapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Accuray Incorporated, Elekta, Isoray Inc., CIVCO, Hitachi, Ltd., Mevion Medical Systems, ProTom International, VIEWRAY TECHNOLOGIES, INC., Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy, Inc., RefleXion, MacroMedics, Vision RT Ltd., and Qfix
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global radiotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiotherapy market
Detailed Segmentation:
- Global Radiotherapy Market, By Product Type:
- External Beam Radiation
- Compact Advanced Radiotherapy Systems
- Cyber Knife
- Gamma Knife
- Others
- Proton Therapy Systems
- High Energy Linear Accelerators (LINAC)
- Internal Beam Radiation
- Applicators
- Afterloader
- Seeds
- Systemic Radiation
- Global Radiotherapy Market, By Therapy Type:
- External Beam Radiation Therapy
- Stereotactic Radiosurgery (SRS)
- Stereotactic Body Radiation Therapy (SBRT)
- Intensity-modulated Radiation Therapy (IMRT)
- Proton Therapy
- Image-guided Radiotherapy (IGRT)
- Volumetric Modulated Arc Therapy (VMAT)
- Others
- Internal Beam Radiation Therapy
- Low-dose Rate Brachytherapy (LDR)
- High-dose Rate Brachytherapy (HDR)
- Image-guided Brachytherapy (IGBT)
- Pulse Dose Rate Brachytherapy (PDR)
- Systemic Radiation Therapy
- Global Radiotherapy Market, By Application:
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
- Global Radiotherapy Market, By End User:
- Hospitals
- Oncology Clinics
- Ambulatory Radiotherapy Centers
- Global Radiotherapy Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Accuray Incorporated
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elekta
- Isoray Inc.
- CIVCO
- Hitachi, Ltd.
- Mevion Medical Systems
- ProTom International
- VIEWRAY TECHNOLOGIES, INC.
- Panacea Medical Technologies Pvt. Ltd.
- Optivus Proton Therapy, Inc.
- RefleXion
- MacroMedics
- Vision RT Ltd.
- Qfix
“*” marked represents similar segmentation in other categories in the respective section.
